Posted at 29 Nov, 14:41h in Press Release by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals Establishes Scientific Advisory Board and Appoints Global Thought Leader in the Field of Alcohol Use Disorder
Posted at 13 Nov, 14:49h in Press Release by adialpharma 0 Comments 0 Likes Share Addiction Drug Developer Adial Pharmaceuticals Receives Notice of Allowance of Canadian Patent for AD04 in Alcohol Use Disorder
Posted at 02 Nov, 14:02h in Press Release by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
Posted at 26 Sep, 15:12h in Press Release by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals to Present at The MicroCap Conference on October 1st in New York City
Posted at 18 Sep, 15:13h in Press Release by adialpharma 0 Comments 0 Likes Share Addiction Drug Developer Adial Pharmaceuticals Successfully Passes Patent Opposition Period in Europe for AD04 in Alcohol Use Disorder; Reports No Challenges to European Patent
Posted at 12 Sep, 15:14h in Press Release by adialpharma 0 Comments 0 Likes Share Alcohol Use Disorder Drug Candidate from Adial Pharmaceuticals Shows Positive Stability Results
Posted at 04 Sep, 15:14h in Press Release by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals to Ring the Nasdaq Stock Market Opening Bell this Morning at 9:30 AM Eastern
